This spring, Claritin is encouraging allergy sufferers to try the challenge for themselves for continuous relief and is offering a money back guarantee. For more details on the challenge and the money back guarantee, visit www.ClaritinChallenge.com and Brooke's full story can be seen at YouTube.com/Claritin.
All CLARITIN® brand products are non-drowsy and available without a prescription. CLARITIN products provide powerful allergy relief for 12 or 24 hours and come in a variety of forms, including: CLARITIN Tablets, CLARITIN® Liqui-Gels®, an easy-to-swallow liquid-filled capsule, and CLARITIN RediTabs® tablets, a quickly dissolving tablet for ages 6 and older.
CLARITIN-D® tablets are available behind-the-counter in 12- or 24-hour extended release tablets and also include the decongestant pseudoephedrine for powerful nasal congestion relief.
CHILDREN'S CLARITIN® comes in great-tasting Grape Chewables or Syrup forms and provides allergy relief for kids 2 and older.
CLARITIN is the No. 1 physician-recommended and pediatrician-recommended non-drowsy over-the-counter allergy brand. The CLARITIN Rx-to-OTC switch in 2002 was the largest switch ever -- and the first for a non-drowsy antihistamine. For more information on allergies and treatment, visit www.CLARITIN.com
About Merck Consumer Care
Today's Merck is a global healthcare leader working to help the world be well. Merck Consumer Care is a subsidiary of Merck & Co., Inc. Each day, millions count on one or more of our industry-leading brands that help prevent or treat various common conditions. These include household names such as CLARITIN® for allergies, COPPERTONE® for sun care, DR. SCHOLL'S® for foot care, and many more. For more information, visit www.merck.com and connect with us on Twitter, Facebook and YouTube.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2262936
Add to Digg Bookmark with del.icio.us Add to Newsvine
Most Popular Stories
- Slow Week Ahead of December FOMC Meeting
- Hispanics Seek to Grow School Board Members
- 'Knockout Game': Myth or Menace?
- U.S. Companies Eager for Iranian Business
- Questions Remain in Jenni Rivera's Death
- Banks Fret as Volcker Vote Approaches
- Entrepreneurs' Next Creation May Be New Laws
- GM Bailout Saved 1.2 Million U.S. Jobs, Report Says
- Bitcoin Used to Buy Tesla Car
- Paul Walker Fans Pay Respects